Discovery of a novel class of exquisitely selective mesenchymal-epithelial transition factor (c-MET) protein kinase inhibitors and identification of the clinical candidate 2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyraz (Q27682048)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q61771980)
(Q57178561)
(P304) 8091-8109
(P407) (Q1860)
(P433) 18
(P478) 55
(P577) Monday, September 10, 2012
(P1433) (Q900316)
(P1476) "Discovery of a novel class of exquisitely selective mesenchymal-epithelial transition factor (c-MET) protein kinase inhibitors and identification of the clinical candidate 2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol (PF-04217903) for the treatment of cancer" (language: en)
(P2093) J Jean Cui
Michele McTigue
Mitchell Nambu
Michelle Tran-Dubé
Mason Pairish
Hong Shen
Lei Jia
Hengmiao Cheng
Jacqui Hoffman
Phuong Le
Mehran Jalaie
Kevin Ryan
Neil Grodsky
Ya-li Deng
Max Parker
Sergei Timofeevski
Shinji Yamazaki
Shirley Aguirre
Qiuhua Li
Helen Zou
James Christensen
other details
description scientific article

External Links